Aging & Disease Reports Transplantation of ACE2- Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia
The COVID-19 pandemic has the global medical profession working around the clock looking for vaccines and therapies.
The journal Aging & Disease has recently reported on a study that has proven transplantation of mesenchymal stem cells has improved the outcome of 7 patients diagnosed with COVID-19 Pneumonia in Bejing, China. Celltex is continuing to monitor this effective research.
If you currently have your MSCs banked at Celltex and are wondering what options are available to you, please contact the Client Services team today by completing the form on our Request a Consultation page, by calling (713) 590-1000 or sending an email to email@example.com. If you are not a client but would like to bank your MSCs, please complete our online client assessment and a Client Services Coordinator will contact you.
More Recent News
Legendary Football Coach and Celltex Sports Program Manager Inducted to Pitt Athletics Hall of Fame 2020 ClassRead More
Bedridden child matures into a healthy mother of two thanks to stem cells
Sarah spent most of her life in a hospital bed until Celltex used her own stem cells to heal her body. She’s doing better than anyone ever imagined, and now she’s helping others who are desperate for medical help.Read More